[시장보고서]세계의 콜레라 백신 시장 : 제품 유형별, 백신 유형별, 환자 유형별, 유통 채널별, 지역별(2025-2032년)

세계의 콜레라 백신 시장 : 제품 유형별, 백신 유형별, 환자 유형별, 유통 채널별, 지역별(2025-2032년)

Global Cholera Vaccines Market, By Product Type, By Vaccine Type, By Patient Type, By Distribution Channel, By Geography

상품코드 : 1705972

리서치사 : Coherent Market Insights

발행일 : 2025년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,485,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000

￦ 10,089,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000

￦ 14,413,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 콜레라 백신 시장은 2025년 8,270만 달러로 추정되고, 2032년까지 1억 8,510만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 12.20%의 복합 연간 성장률(CAGR)로 성장할 전망입니다.

보고 범위		보고서 세부정보
기준연도	2024년	2025년 시장 규모	8,270만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간: 2025-2032년 CAGR:	12.20%	2032년 가치 예측	1억 8,510만 달러

그림. 콜레라 백신 세계 시장 점유율(%), 2025년 지역별

콜레라는 박테리아성 질환으로, 통상은 오염된 물을 통해 퍼집니다. 격렬한 설사와 탈수 증상을 일으켜, 방치하면 수시간에 죽음에 이르기도 합니다. 세계보건기구(WHO)와 유엔아동기금(UNICEF)은 콜레라가 괴멸적인 부활을 이루고 있으며, 특히 취약한 지역사회를 표적으로 하고 있다고 경고하고 있습니다. 콜레라 유행의 위험성이 가장 높은 곳은 빈곤, 전쟁, 자연재해에 의해 사람들이 충분한 위생 설비도 없는 혼잡한 환경에서 사는 것을 강요당한 경우입니다. 콜레라를 제압해, 사망자를 줄이려면, 예방의 관점에서 다면적인 접근이 중요합니다. 이것에는 안전한 물, 적절한 위생 설비, 위생 상태의 확보, 리스크가 높은 지역에서의 백신 접종 등이 포함됩니다.

시장 역학:

세계 콜레라 백신 시장의 성장을 가속하는 주요 요인으로는 세계 콜레라 질환의 부담 증가, 콜레라 발생 예방에 대한 관심 증가, 방어 기간이 긴 신규 경구 백신 시장 개척 등이 있습니다. 낙관적인 견해를 하면, 복수의 혈청형에 대한 교차 방어를 제공하는 백신의 조사에 대한 투자가 증가하고 있어 새로운 길이 열리고 있습니다.

본 조사의 주요 특징

본 보고서에서는 콜레라 백신 세계 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측 기간 중(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR)을 제공합니다.
또, 다른 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 설명하고 있습니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
본 보고서에서는 콜레라 백신 세계 시장에서 주요 기업 프로파일을 기업 하이라이트, 제품 포트폴리오, 주요 제품 하이라이트, 실적, 전략 등의 파라미터에 따라 제공합니다.
본 보고서로부터 얻을 수 있는 인사이트에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 출시, 타입 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
콜레라 백신 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자에 대응하고 있습니다.
세계 콜레라 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 이해관계자는 의사결정이 용이해집니다.

시장 역학
- 예방접종 캠페인 강화
- 콜레라 백신 공급 부족
- 교육훈련 프로그램 증가
주요 하이라이트
규제 시나리오
시장 동향
파이프라인 분석
제품 출시/승인
PEST 분석
PORTER 분석
역학
치료 알고리즘(환자 여정)
치료 옵션 분석
주요 시장 기업에 의한 신규 투자
가격 분석
질병 계발 프로그램
치료의 안전성과 효능의 분석
합병, 인수 및 제휴

제4장 세계의 콜레라 백신 시장- 코로나바이러스(COVID-19) 팬데믹의 영향

COVID-19 역학
공급측과 수요측의 분석
경제에 미치는 영향

제5장 세계의 콜레라 백신 시장 : 제품 유형별, 2020-2032년

Vaxchora
Dukoral
ShanChol
Euvichol-Plus/Euvichol
기타(후기 백신 등)

제6장 세계의 콜레라 백신 시장 : 백신 유형별, 2020-2032년

불활성화 전세포 및 재조합 콜레라 독소 B 백신
불활성화 전세포 백신
생 약독화 경구 콜레라 백신

제7장 세계의 콜레라 백신 시장 : 환자 유형별, 2020-2032년

소아
성인

제8장 세계의 콜레라 백신 시장 : 유통 채널별, 2020-2032년

공공
민간

제9장 세계의 콜레라 백신 시장 : 지역별, 2020-2032년

북미
유럽
아시아태평양
라틴아메리카
중동
아프리카

제10장 경쟁 구도

기업 프로파일
- Sanofi
- Biovac.co.za.
- EMERGENT
- Celldex Therapeutics
- Valneva SE
- Hilleman Laboratories
- Shanghai United Cell Biotechnology Co., Ltd(Hillhouse Capital)
- PaxVax, Inc.
- Astellas Pharma Inc.
- EUBIOLOGICS CO., LTD.

제11장 섹션

참고문헌
조사 방법
출판사에 대해

JHS

영문 목차

영문목차

Global Cholera Vaccines Market is estimated to be valued at USD 82.7 Mn in 2025 and is expected to reach USD 185.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.20% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 82.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.20%	2032 Value Projection:	USD 185.1 Mn

Figure. Global Cholera Vaccines Market Share (%), By Region 2025

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inadequate hygiene, such as Africa, Southeast Asia, and Haiti. The World Health Organization (WHO) and the UN Children's Fund (UNICEF) have warned that cholera is making a devastating comeback, particularly targeting vulnerable communities. The risk of a cholera epidemic is highest when poverty, war, or natural disasters force people to live in crowded conditions without adequate sanitation. Cholera is a disease of poverty, affecting people with inadequate access to safe water and basic sanitation. The infection is not likely to spread directly from one person to another; therefore, casual contact with an infected person is not a significant risk factor for becoming ill. In terms of prevention, a multifaceted approach is key to controlling cholera and reducing deaths. This includes ensuring access to safe water, adequate sanitation, and hygiene, as well as vaccination in high-risk areas.

Market Dynamics:

Key drivers favoring the growth of global cholera vaccines market include the rising burden of cholera disease globally, growing focus on preventing cholera outbreaks, and the development of novel oral vaccines with a longer duration of protection. However, factors such as insufficient access to vaccines in low-income regions, and a lack of awareness about immunization in certain communities continue to restrain the market potential to a certain extent. On the optimistic side, increasing investments in the research of vaccines providing cross-protection against multiple serotypes open up new avenues. Partnerships between makers and international organizations for improving availability in endemic areas also present attractive opportunities over the next few years.

Key features of the study:

This report provides in-depth analysis of the global cholera vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cholera vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cholera vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholera vaccines market

Detailed Segmentation:

Global Cholera Vaccines Market, By Product Type
- Vaxchora
- Dukoral
- ShanChol
- Euvichol-Plus/Euvichol
- Others (Late Phase Vaccines, etc.)
Global Cholera Vaccines Market, By Vaccine Type
- Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
- Killed Whole-cell Only Vaccines
- Live Attenuated Oral Cholera Vaccine
Global Cholera Vaccines Market, By Patient Type
- Pediatric
- Adults
Global Cholera Vaccines Market, By Distribution Channel
- Public
- Private
Global Cholera Vaccines Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Sanofi
- Biovac.co.za.
- EMERGENT
- Celldex Therapeutics
- Valneva SE
- Hilleman Laboratories
- Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
- PaxVax, Inc.
- Astellas Pharma Inc.
- EUBIOLOGICS CO., LTD.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Vaccine Type
- Market Snippet, By Patient Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing Vaccination Campaigns
- Supply Shortage of Cholera Vaccine
- Increasing Educational Training Programmes
Key Highlights
Regulatory Scenario
Market Trends
Pipeline Analysis
Product Launch/Approval
PEST Analysis
PORTER's Analysis
Epidemiology
Treatment Algorithm (Patient Journey)
Treatment Option Analysis
New Investments by Major Market Players
Pricing Analysis
Disease Awareness Programs
Treatment Safety and Efficacy Analysis
Mergers, Acquisitions, and Collaborations

4. Global Cholera Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Cholera Vaccines Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Vaxchora
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Dukoral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
ShanChol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Euvichol-Plus/Euvichol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Late Phase Vaccines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Cholera Vaccines Market, By Vaccine Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Killed Whole-cell Only Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Live Attenuated Oral Cholera Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Cholera Vaccines Market, By Patient Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Cholera Vaccines Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 201s9-2032,(US$ Mn)

9. Global Cholera Vaccines Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profile
- Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Biovac.co.za.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- EMERGENT
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Celldex Therapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Valneva SE
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Hilleman Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- PaxVax, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Astellas Pharma Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- EUBIOLOGICS CO., LTD.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

11. Section

References
Research Methodology
About us